These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27799295)

  • 1. The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.
    Miller SL; Aroniadou-Anderjaska V; Pidoplichko VI; Figueiredo TH; Apland JP; Krishnan JK; Braga MF
    J Pharmacol Exp Ther; 2017 Jan; 360(1):23-32. PubMed ID: 27799295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure.
    Prager EM; Aroniadou-Anderjaska V; Almeida-Suhett CP; Figueiredo TH; Apland JP; Braga MF
    Neurotoxicology; 2013 Sep; 38():84-90. PubMed ID: 23817175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala.
    Prager EM; Pidoplichko VI; Aroniadou-Anderjaska V; Apland JP; Braga MF
    Neurotoxicology; 2014 Sep; 44():335-43. PubMed ID: 25150775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior.
    Prager EM; Aroniadou-Anderjaska V; Almeida-Suhett CP; Figueiredo TH; Apland JP; Rossetti F; Olsen CH; Braga MF
    Neuropharmacology; 2014 Jun; 81():64-74. PubMed ID: 24486384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.
    Sheffler DJ; Williams R; Bridges TM; Xiang Z; Kane AS; Byun NE; Jadhav S; Mock MM; Zheng F; Lewis LM; Jones CK; Niswender CM; Weaver CD; Lindsley CW; Conn PJ
    Mol Pharmacol; 2009 Aug; 76(2):356-68. PubMed ID: 19407080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.
    Miller SL; Aroniadou-Anderjaska V; Figueiredo TH; Prager EM; Almeida-Suhett CP; Apland JP; Braga MF
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):204-16. PubMed ID: 25689173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure.
    Tetz LM; Rezk PE; Ratcliffe RH; Gordon RK; Steele KE; Nambiar MP
    Toxicol Ind Health; 2006 Jul; 22(6):255-66. PubMed ID: 16924957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam and isoflurane combination reduces late brain damage in the paraoxon-induced status epilepticus rat model.
    Swissa E; Bar-Klein G; Serlin Y; Weissberg I; Kamintsky L; Eisenkraft A; Statlender L; Shrot S; Rosman Y; Prager O; Friedman A
    Neurotoxicology; 2020 May; 78():99-105. PubMed ID: 32084435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats.
    de Araujo Furtado M; Lumley LA; Robison C; Tong LC; Lichtenstein S; Yourick DL
    Epilepsia; 2010 Aug; 51(8):1503-10. PubMed ID: 20067510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.
    Loughery TN; Whitten KA; Acon-Chen C; Shih TM
    Toxicol Appl Pharmacol; 2021 May; 419():115515. PubMed ID: 33798593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety.
    Prager EM; Figueiredo TH; Long RP; Aroniadou-Anderjaska V; Apland JP; Braga MF
    Neuropharmacology; 2015 Feb; 89():11-8. PubMed ID: 25204221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam Treatment.
    De Araujo Furtado M; Aroniadou-Anderjaska V; Figueiredo TH; Pidoplichko VI; Apland JP; Rossetti K; Braga MFM
    J Pharmacol Exp Ther; 2024 Jan; 388(2):432-450. PubMed ID: 37739807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy.
    Aroniadou-Anderjaska V; Figueiredo TH; Apland JP; Braga MF
    Neurobiol Dis; 2020 Jan; 133():104406. PubMed ID: 30798006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological blockade of the calcium plateau provides neuroprotection following organophosphate paraoxon induced status epilepticus in rats.
    Deshpande LS; Blair RE; Huang BA; Phillips KF; DeLorenzo RJ
    Neurotoxicol Teratol; 2016; 56():81-86. PubMed ID: 27224207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment.
    Shrot S; Ramaty E; Biala Y; Bar-Klein G; Daninos M; Kamintsky L; Makarovsky I; Statlender L; Rosman Y; Krivoy A; Lavon O; Kassirer M; Friedman A; Yaari Y
    Toxicology; 2014 Sep; 323():19-25. PubMed ID: 24881594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors.
    Navarria A; Wohleb ES; Voleti B; Ota KT; Dutheil S; Lepack AE; Dwyer JM; Fuchikami M; Becker A; Drago F; Duman RS
    Neurobiol Dis; 2015 Oct; 82():254-261. PubMed ID: 26102021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of status epilepticus induced by two organophosphates in rats.
    Todorovic MS; Cowan ML; Balint CA; Sun C; Kapur J
    Epilepsy Res; 2012 Sep; 101(3):268-76. PubMed ID: 22578704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.
    Apland JP; Aroniadou-Anderjaska V; Figueiredo TH; Prager EM; Olsen CH; Braga MFM
    Neurotox Res; 2017 Nov; 32(4):694-706. PubMed ID: 28776308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin and the Protease-Activated Receptor-1 in Organophosphate-Induced Status Epilepticus.
    Golderman V; Shavit-Stein E; Gera O; Chapman J; Eisenkraft A; Maggio N
    J Mol Neurosci; 2019 Feb; 67(2):227-234. PubMed ID: 30515700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
    Figueiredo TH; Aroniadou-Anderjaska V; Apland JP; Rossetti K; Braga MF
    Exp Biol Med (Maywood); 2023 Apr; 248(7):612-623. PubMed ID: 37300407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.